The diagnostic and therapeutic approach for primary solid liver tumours in adults

Best Practice and Research: Clinical Gastroenterology

Volumn 21, Issue 6, 2007, Pages 983-996

  Verslype, Chris ^a   Libbrecht, Louis ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

adenoma; focal liver lesion; hepatocellular carcinoma; tumour like lesions

Indexed keywords

CISPLATIN; FLUOROURACIL; GEMCITABINE; PLACEBO; SORAFENIB;

ADULT; ARTICLE; BILE DUCT; BILE DUCT CARCINOMA; CANCER CHEMOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DRUG TOLERABILITY; HEMANGIOENDOTHELIOMA; HUMAN; IMAGING SYSTEM; LIVER ADENOMA; LIVER CANCER; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER HEMANGIOMA; LIVER NODULE; MESENCHYME; METASTASIS; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; SOLID TUMOR; ULTRASOUND; BILE DUCT TUMOR; HEMANGIOMA; INTRAHEPATIC BILE DUCT; LIVER TUMOR; PATHOLOGY; PRECANCER; REVIEW;

ADENOMA, LIVER CELL; ADULT; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; FOCAL NODULAR HYPERPLASIA; HEMANGIOMA; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 36749086419     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2007.09.006     Document Type: Article

References (47)

1. Goodman Z.D., and Terracciano L.M. Tumours and tumour-like lesions of the liver. In: Burt A.D., Portmann B.C., and Ferrell L.D. (Eds). MacSween's pathology of the liver. 5th ed. (2007), Churchill Livingstone, London 761-814
2. Bruix J., and Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
3. Chang M.H., Chen C.J., Lai M.S., et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Eng J Med 336 (1997) 1855-1859
4. Bruix J., Sherman M., and Llovet J.M. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35 (2001) 421-430
5. Kojiro M., and Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis 25 (2005) 133-142
6. Hussain S.M., Zodervan P.E., Ijzermans J.N., et al. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 22 (2002) 1023-1039
7. Lencioni R., Cioni D., and Crocetti L. Magnetic resonance imaging of liver tumors. J Hepatol 40 (2004) 162-171
8. Lencioni R., Cioni D., Della Pina C., et al. Imaging diagnosis. Semin Liver Dis 25 (2005) 162-170
9. Shimizu A., Ito K., and Koike S. Cirrhosis or chronic hepatitis: evaluation of small (< or =2-cm) early-enhancing hepatic lesions with serial contrast enhanced dynamic MR imaging. Radiology 226 (2003) 550-555
10. Libbrecht L., Bielen D., Verslype C., et al. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 8 (2002) 749-761
11. Lee Y.H., Kim S.H., Cho M.Y., et al. Focal nodular hyperplasia-like nodules in alcoholic liver cirrhosis: radiologic-pathologic correlation. AJR Am J Roentgenol 188 (2007) 459-463
12. Libbrecht L., Cassiman D., Verslype C., et al. Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers. Am J Gastroenterol 101 (2006) 2341-2346
13. Yu J.S., Cho E.S., Kim K.H., et al. Newly developed hepatocellular carcinoma (HCC) in chronic liver disease: MR imaging findings before the diagnosis of HCC. J Comput Assist Tomogr 30 (2006) 765-771
14. Giannelli G., and Antonaci S. New frontiers in biomarkers for hepatocellular carcinoma. Digest Liver Dis 38 (2006) 854-859
15. Llovet J., Ricci S., Mazzaferro V., et al. Sorafenib improves survival in advanced Hepatocellular Carcinoma (HCC): results of a Phase III randomized placebo-controlled trial (SHARP trial). J Clin Oncol 2007 ASCO Annual Meeting Proceedings 25 (2007) LBA1
16. Durnez A., Verslype C., Nevens F., et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 49 (2006) 138-151
17. Ishak K.G., and Rabin L. Benign tumors of the liver. Med Clin North Am 59 (1975) 995-1013
18. Yoon S.S., Charny C.K., Fong Y., et al. Diagnosis, management, and outcomes of 115 patients with hepatic haemangioma. J Am Coll Surg 197 (2003) 392-402
19. Terriff B.A., Gibney R.G., and Scudamore C.H. Fatality from fine-needle aspiration biopsy of a hepatic haemangioma. Am J Roentgenol 154 (1990) 203-204
20. Jang H.J., Kim T.K., Lim H.K., et al. Hepatic hemangioma: atypical appearances on CT, MR imaging, and sonography. AJR Am J Roentgenol 180 (2003) 135-141
21. Okano H., Shiraki K., Inoue H., et al. Natural course of cavernous hepatic haemangioma. Oncol Rep 8 (2001) 411-414
22. Charny C.K., Jarnagin W.R., Schwartz L.H., et al. Management of 155 patients with benign liver tumours. Br J Surg 88 (2001) 808-813
23. Cappellani A., Zanghi A., Di Vita M., et al. Spontaneous rupture of a giant haemangioma of the liver. Ann Ital Chir 71 (2000) 379-383
24. Farges O., Daradkeh S., and Bismuth H. Cavernous haemangiomas of the liver: are there any indications for resection?. World J Surg 19 (1995) 19-24
25. Srivastava D.N., Gandhi D., Seith A., et al. Transcatheter arterial embolization in the treatment of symptomatic cavernous haemangiomas of the liver: a prospective study. Abdom Imaging 26 (2001) 510-514
26. Gaspar L., Mascarenhas F., da Costa M.S., et al. Radiation therapy in the unresectable cavernous haemangioma of the liver. Radiother Oncol 29 (1993) 45-50
27. Russo M.W., Johnson M.W., Fair J.H., and Brown Jr. R.S. Orthotopic liver transplantation for giant hepatic haemangioma. Am J Gastroenterol 92 (1997) 1940-1941
28. Rooks J.B., Ory H.W., Ishak K.G., et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242 (1979) 644-648
29. Hussain S.M., and Semelka R.C. Hepatic imaging: comparison of modalities. Radiol Clin North Am 43 (2005) 929-947
30. Bioulac-Sage P., Balabaud C., Bedossa P., et al. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol 46 (2007) 521-527
31. Bioulac-Sage P., Rebouissou S., Sa Cunha A., et al. Clinical, morphological and molecular features defining so called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 128 (2005) 1211-1218
32. Zucman-Rossi J., Jeannot E., Nhieu J.T., et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43 (2006) 515-524
33. Bioulac-Sage P., Rebouissou S., Thomas C., et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46 (2007) 740-748
34. van der Windt D.J., Kok N.F.M., Hussain S.M., et al. Case-orientated approach to the management of hepatocellular adenoma. Br J Surg 93 (2006) 1495-1502
35. Paradis V., Bieche I., Dargere D., et al. A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia. Gastroenterology 124 (2003) 651-659
36. Mortelé K.J., Praet M., Van Vlierberghe H., et al. CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation. Am J Roentgenol 175 (2000) 687-692
37. Vilgrain V. Focal nodular hyperplasia. Eur J Radiol 58 (2006) 236-245
38. Hussain S.M., Terkivatan T., Zondervan P.E., et al. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 24 (2004) 3-17
39. Makhlouf H.R., Abdul-Al H.M., and Goodman Z.D. Diagnosis of focal nodular hyperplasia of the liver by needle biopsy. Hum Pathol 36 (2005) 1210-1216
40. Shahip Y., and El-Sarag H.B. The epidemiology of cholangiocarcinoma. Sem Liver Dis 24 (2004) 115-124
41. Fevery J., Verslype C., Lai G., et al. Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis. Dig Dis Sci 52 (2007) 3123-3135
42. Soyer P., Bluemke D.A., Reichle R., et al. Imaging of intrahepatic cholangiocarcinoma: 1. Peripheral cholangiocarcinoma. AJR Am J Roentgenol 165 (1995) 1427-1431
43. Nakeeb A., Tran K.Q., Black M.J., et al. Improved survival in resected biliary malignancies. Surgery 132 (2002) 555-563
44. Herman T.E., and Siegel M.J. Special imaging casebook. Infantile hepatic haemangioendothelioma. J Perinatol 20 (2000) 447-449
45. Makhlouf H.R., Ishak K.G., and Goodman Z.D. Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases. Cancer 85 (1999) 562-582
46. Kim K.A., Kim K.W., Park S.H., et al. Unusual mesenchymal liver tumors in adults: radiologic-pathologic correlation. AJR Am J Roentgenol 187 (2006) W481-W489
47. Gaiani S., Celli N., Piscaglia F., et al. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 41 (2004) 421-426